Skip to content
Politically.com Search all
Menu

2025 · 2nd Quarter (Apr 1 - June 30)

ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC.

Filed by ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 21, 2025
Income
Not reported
Expenses
$220,000.00
Filing UUID
39947d3c-74e4-4ac3-9104-6ff526201d81
Termination date
Not reported

Expense method: C

Literal source text

Lobbying issues and bill citations

DEF · Defense

H.R. 2707, Protecting American Families and Servicemembers From Anthrax Act National Defense Authorization Act, 2026 Appropriations Legislation, 2026 Pandemic All Hazards and Preparedness Act Reauthorization

Literal federal measure citations: H.R. 2707

HCR · Health Issues

H.R. 2707, Protecting American Families and Servicemembers From Anthrax Act National Defense Authorization Act, 2026 Appropriations Legislation, 2026 Pandemic All Hazards and Preparedness Act Reauthorization

Literal federal measure citations: H.R. 2707

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.